GR

Gaurav Rajaram Deore

Active Director Designated Partner DIN 09264450
DIN 09264450 First appointment Aug 2021 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Gaurav Rajaram Deore

Data last updated:

Gaurav Rajaram Deore is a Designated Partner at Medtricare Clinical Research Solutions Llp (since 2021). The company operates in Business Services.

DIN 09264450
Primary Designation Designated Partner
Industry Business Services
First Appointment 02 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Aug 20212021Active

Board colleagues of Gaurav Rajaram Deore

Directorship timeline

Open interactive timeline →
Medtricare Clinical Research Solutions Llp
Premium access

Shareholding and investment profile for Gaurav Rajaram Deore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Rajaram Deore

Gaurav Rajaram Deore currently holds 1 directorship: Medtricare Clinical Research Solutions Llp (Designated Partner, since 02 Aug 2021).

Gaurav Rajaram Deore was first appointed on 02 Aug 2021 as Designated Partner at Medtricare Clinical Research Solutions Llp.

The current boards of Gaurav Rajaram Deore's companies include Dhananjay Ganesh Satpute (Medtricare Clinical Research Solutions Llp), Kunal Rajaram Deore (Medtricare Clinical Research Solutions Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available